Phaarmasia Q1 FY27 results: revenue up 20.5%, PAT at Rs 33.9 lakh

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.9%Reaction day

₹84.50

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-8.9% vs market

Pharmaceuticals peers, median of 166sector-0.4%-8.5% vs sector

On the reaction day the stock moved 8.9 pts less than Nifty Microcap 250 and 8.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.9+0.1-8.9-0.4-8.5

Next day

-9.3+0.2-9.5-0.3-9.0

-18.4+0.6-19.0-0.5-17.8

-9.5-0.0-9.5-1.3-8.2

-8.4+0.5-8.9-0.8-7.6

-10.1+0.8-10.8-0.4-9.7

-10.1+0.6-10.6-0.9-9.2

15d

-2.7+1.3-3.9+0.0-2.7

+0.6-1.4+1.9-0.1+0.7

-4.3-0.6-3.7-2.6-1.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Phaarmasia posted Q1 FY27 revenue of Rs 828.33 lakh, up 20.5% from Rs 687.36 lakh in Q1 FY26. Total income rose to Rs 858.46 lakh from Rs 718.88 lakh. Net profit grew 25.5% to Rs 33.90 lakh from Rs 27.02 lakh. EPS stood at Rs 0.50 vs Rs 0.40. The company has zero total debt and no loan defaults. Limited review by Sathuluri and Co was clean with no qualifications.

Likely market impact

Strong topline growth and higher profit with a debt-free balance sheet signal healthy operations, though absolute profits remain small.